ImVisioN Therapeutics imvision-therapeutics.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1148)

Imvision2ImVisioN Therapeutics AG (Muttenz, Switzerland) is engaged in intralymphatic immunotherapy (ILIT), a technology for the delivery of immunotherapeutics in the treatment of allergies. ImVisioN's lead product for the treatment of cat dander allergy is in clinical development.

Imvision2ImVisioN Therapeutics AG (Muttenz, Switzerland) is engaged in intralymphatic immunotherapy (ILIT), a technology for the delivery of immunotherapeutics in the treatment of allergies. ImVisioN's lead product for the treatment of cat dander all...Show all

Company (Alive / Active)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ImVisioN Therapeutics $0M May 20, 2019
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ImVisioN Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors

Board Members

Competitors

Company Status Description Investors
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)